Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000919574-15-004978
Filing Date
2015-06-18
Accepted
2015-06-18 15:27:22
Documents
1
Period of Report
2015-06-16

Document Format Files

Seq Description Document Type Size
1 TIGER/NIVALIS p6663862.html 3  
1 TIGER/NIVALIS p6663862.xml 3 4078
  Complete submission text file 0000919574-15-004978.txt   6045
Mailing Address
Business Address 101 PARK AVENUE NEW YORK NY 10178 2129842500
TIGER PARTNERS LP (Reporting) CIK: 0001132908 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37449 | Film No.: 15940118

Mailing Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301
Business Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301 720-945-7700
Nivalis Therapeutics, Inc. (Issuer) CIK: 0001626199 (see all company filings)

EIN.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 101 PARK AVENUE NEW YORK NY 10178
Business Address 101 PARK AVENUE NEW YORK NY 10178 212-984-2500
Tiger Partners GP, LLC (Reporting) CIK: 0001645585 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37449 | Film No.: 15940117